Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
Riot Platforms
RIOT
CATHEDRA BITCOIN INC
CBTTF
TeraWulf
WULF
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.